ADVERTISEMENT

Online Exclusive

E-Content
ACOG and SMFM weigh in on FDA decision about Compounding Drug used to prevent preterm babies

The following press releases from ACOG, SMFM, FDA, and K-V Pharmaceutical discuss the controversy over Makena.


ADVERTISEMENT
ADVERTISEMENT

Breaking News

More Headlines